| Andrew Buchanan Small Iv, MD | |
|
3901 W 15th Street, Plano, TX 75075 | |
| (972) 596-6800 | |
| Not Available |
| Full Name | Andrew Buchanan Small Iv |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 3901 W 15th Street, Plano, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043268089 | NPI | - | NPPES |
| 8B7904 | Other | TX | COLLIN COUNTY PTAN |
| 168061302 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | L1203 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Presbyterian Hospital Allen | Allen, TX | Hospital |
| Texas Health Presbyterian Hospital Plano | Plano, TX | Hospital |
| Texas Health Presbyterian Hospital Denton | Denton, TX | Hospital |
| Texas Health Harris Methodist Hurst-euless-bedford | Bedford, TX | Hospital |
| University Of Texas Medical Branch Galveston | Galveston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Medical Branch Faculty Group Practice | 3375456734 | 875 |
| Texas Radiology Associates Llp | 3779578000 | 145 |
| Texas Radiology Associates Llp | 3779578000 | 145 |
News Archive
Johns Hopkins researchers have added to the growing mound of evidence that many of the genetic bits and pieces that drive evolutionary changes do not confer any advantages or disadvantages to humans or other animals.
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).
The drug tadalafil appears to improve erectile function in men with spinal cord injuries, according to an article posted online today that will appear in the November 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.
› Verified 1 days ago
| Entity Name | Utmb Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
Johns Hopkins researchers have added to the growing mound of evidence that many of the genetic bits and pieces that drive evolutionary changes do not confer any advantages or disadvantages to humans or other animals.
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).
The drug tadalafil appears to improve erectile function in men with spinal cord injuries, according to an article posted online today that will appear in the November 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.
› Verified 1 days ago
| Entity Name | Texas Radiology Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016161 PECOS PAC ID: 3779578000 Enrollment ID: O20040422001470 |
News Archive
Johns Hopkins researchers have added to the growing mound of evidence that many of the genetic bits and pieces that drive evolutionary changes do not confer any advantages or disadvantages to humans or other animals.
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).
The drug tadalafil appears to improve erectile function in men with spinal cord injuries, according to an article posted online today that will appear in the November 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Buchanan Small Iv, MD 1820 Preston Park Blvd, Ste 1825, Plano, TX 75093-5215 Ph: (972) 867-7862 | Andrew Buchanan Small Iv, MD 3901 W 15th Street, Plano, TX 75075 Ph: (972) 596-6800 |
News Archive
Johns Hopkins researchers have added to the growing mound of evidence that many of the genetic bits and pieces that drive evolutionary changes do not confer any advantages or disadvantages to humans or other animals.
Genentech, Inc. has announced an update for the previously reported Roche-sponsored international Phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy, in patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).
The drug tadalafil appears to improve erectile function in men with spinal cord injuries, according to an article posted online today that will appear in the November 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.
› Verified 1 days ago
Dr. Galon Cory Morgan, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 W 15th St, Plano, TX 75075 Phone: 972-596-6800 | |
Dr. Bao-tram Xuan Nguyen, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 W 15th St, Plano, TX 75075 Phone: 972-596-6800 | |
Dr. Laura Tasa, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 W 15th St, Plano, TX 75075 Phone: 972-596-6800 | |
Dr. James Ken, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 W 15th Street, Plano, TX 75075 Phone: 972-596-6800 | |
Yanqiu Zheng, MD Radiology Medicare: Medicare Enrolled Practice Location: 1820 Preston Park Blvd Ste 2400, Plano, TX 75093 Phone: 972-867-7862 | |
Mark Alan Spivey, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 W 15th St, Plano, TX 75075 Phone: 972-596-6800 |